NEW YORK, NY / ACCESS Newswire / March 13, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn ...

NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Geron ...

Geron Corporation’s GERN share price has surged by 10.63%, which has investors questioning if this is right time to sell.

In this article, we are going to take a look at where Geron Corporation (NASDAQ:GERN) stands against other stocks under $5 with biggest upside potential. On January 20, Bloomberg reported that ...

Geron Corp (GERN) reports a robust cash reserve and key FDA approval for Rytelo, but faces flat revenue trends and leadership changes in its commercial strategy.

In this article, we are going to take a look at where Geron Corp. (NASDAQ:GERN) stands against other best Nasdaq stocks under $5 to buy. The Nasdaq is one of the top three most-followed stock ...

Geron (GERN) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.09 per share a year ago. These figures are ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets ...

Stock analysts at HC Wainwright issued their FY2029 EPS estimates for Geron in a report released on Wednesday, February 26th. HC Wainwright analyst E. Bodnar anticipates that the biopharmaceutical ...